AXNX Live signaler | Maksimer profitt med Getagraph.com

SELG 3673 min ago

@ $67.20

Utstedt: 2 mai 2024 @ 20:55

Avkastning: 0.13%

Forrige signal: mai 2 - 17:14

Forrige signal: Kjøp

Avkastning: 0.52 %

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Stats
Dagens volum	339 726
Gjennomsnittsvolum	856 172
Markedsverdi	3.43B
EPS	$0 ( 2024-03-06 )
Neste inntjeningsdato	( $-0.0500 ) 2024-05-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-217.03
ATR14	$0.580 (0.86%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-31	Sama Rinda	Buy	28 000	Common Stock
2024-01-31	Sama Rinda	Sell	17 500	Performance-Based Restricted Stock Units
2024-01-31	Noblett Karen	Buy	27 500	Common Stock
2024-01-31	Noblett Karen	Sell	11 288	Common Stock
2024-01-31	Noblett Karen	Sell	15 000	Performance-Based Restricted Stock Units

INSIDER POWER
-1.72
Last 98 transactions
Buy: 597 788 \| Sell: 539 127

Volum Korrelasjon

Lang: 0.45 (neutral)

Kort: 0.41 (neutral)

Signal:(59) Neutral

Axonics Modulation Korrelasjon

10 Mest positive korrelasjoner
TIG	0.944
DSKE	0.897
LBPH	0.888
KNBE	0.887
RBKB	0.887
ORTX	0.87
TCON	0.853
VIA	0.852
STTK	0.847
ALOT	0.845

10 Mest negative korrelasjoner
SALM	-0.895
AGIL	-0.872
BJDX	-0.869
EJH	-0.867
WKSP	-0.859
TRVG	-0.853
NMRD	-0.848
ACVA	-0.845
ACAD	-0.844
HALL	-0.84

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Axonics Modulation Korrelasjon - Valuta/Råvare

0.44
( neutral )

0.37
( neutral )

0.00
( neutral )

-0.38
( neutral )

Axonics Modulation Økonomi

Annual	2023
Omsetning:	$366.38M
Bruttogevinst:	$265.49M (72.46 %)
EPS:	$-0.120

FY	2023
Omsetning:	$366.38M
Bruttogevinst:	$265.49M (72.46 %)
EPS:	$-0.120

FY	2022
Omsetning:	$273.70M
Bruttogevinst:	$197.67M (72.22 %)
EPS:	$-1.280

FY	2021
Omsetning:	$180.29M
Bruttogevinst:	$115.72M (64.18 %)
EPS:	$-2.17

Financial Reports:

No articles found.

Axonics Modulation

Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.

Sanntidsoppdatering for Axonics Modulation [AXNX]

Upcoming Earnings Alert